German auto manufacturer BMW AG yesterday said that its profits dipped in the second quarter of this year as supply bottlenecks and Chinese COVID-19 lockdowns knocked production.
The automaker’s profits for the period between April and June fell to 3 billion euros (US$3.1 billion) from 4.8 billion euros in the same period last year.
BMW CEO Oliver Zipse recognized “unfavorable conditions,” but said in a statement that the Munich-based group had shown “a high degree of resilience.”
“Ongoing semiconductor supply issues and supply chain disruptions following COVID lockdowns in China,” a key market for automakers, held back production in the first half of the year, BMW said in a statement.
BMW shipped just more than 563,000 units in the second quarter of this year, a drop of 19.8 percent from a year earlier.
Like other premium automakers, the limits to production meant that BMW leaned more heavily on its top-of-the-range models with bigger margins.
The group benefited from this better “product mix” and higher prices for its vehicles, which partially offset the fall in the number of vehicles sold, BMW said.
The group said economic conditions would “remain difficult” in the second half of this year, with the war in Ukraine also disrupting supply and weighing on the industry.
Unit sales in the second half would be “solidly higher,” BMW said, but would “not fully compensate for lost volume” in the first half, meaning deliveries of its vehicles would now be “slightly below” the level of last year.
Strong demand and recent tight supply meant BMW had an “above-average order bank.”
However, high inflation on the back of soaring energy prices would cool the economy and see BMW’s order backlog “normalize towards the end of the year.”
BMW’s predictions did not take into account the impact that a cut to Russian gas supplies to Europe could have on its production locally.
GlaxoSmithKline (GSK) in July made its consumer health products division a separate entity as it transforms into a world-leading biopharmaceutical company. By uniting science, technology and talent, the company is aiming to prevent and treat diseases with innovative vaccines, specialty pharmaceuticals and general medicines. GSK’s headquarters annually invests NT$192 billion (US$6.07 billion) in research and development, focusing on immune science and advanced technologies in human genetics. GSK’s drug and vaccine development focuses on infectious diseases, HIV, oncology and immunology. Investing in clinical trial research each year, GSK also brings drug development to Taiwan. It cooperates with 17 medical institutes and research
SLUMPING DEMAND: Inventory has climbed by up to 12 weeks as suppliers are under mounting pressure to offload excessive reserves, a TrendForce report said The price of DRAM chips is expected to fall at a steeper rate of 13 to 18 percent next quarter, as high inflation continues to weigh on demand for consumer electronics, causing chip inventories to soar, market researcher TrendForce Corp (集邦科技) said yesterday. The downtrend in DRAM prices could extend from a quarterly decline of 10 to 15 percent in the third quarter, the Taipei-based researcher said. “Demand for consumer electronics continued to stagnate during the third quarter, which used to be a high demand season,” TrendForce said in a statement. “During the quarter, memorychip consumption and shipments both showed quarterly
INEXPENSIVE POWER: Group chairman Gautam Adani said 70% of the investment would go into energy transition, with a focus on green hydrogen India’s Adani Group is to invest more than US$100 billion over the next decade, most of it in the energy transition business, chairman Gautam Adani said yesterday, as the ports-to-energy conglomerate accelerates an already aggressive expansion plan. After founding the group in 1988 as a commodities trading business, the 60-year-old has ventured into multiple sectors, mainly in the infrastructure space and in line with the priorities of the government of Indian Prime Minister Narendra Modi. “As a group, we will invest over US$100 billion of capital in the next decade,” Adani, the world’s second-richest person, told the Forbes Global CEO Conference in
Foxconn Technology Group (富士康科技集團) is to invest US$1.75 million in a joint venture with PT Indika Energy Tbk to explore commercial electric vehicle (EV) and electric battery business opportunities in Indonesia, the Taipei-based company said yesterday. With the investment, Foxconn would hold a 40 percent stake in the joint venture, PT Foxconn Indika Motor, while PT Indika would own 60 percent. The collaboration is an extension of a memorandum of understanding signed in January by Indika Energy, Foxconn, Gogoro Inc (睿能創意) and others aiming to build an electric vehicle supply chain in Southeast Asia’s biggest economy. Gogoro, in which Foxconn owns a 0.76